BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20704554)

  • 1. Disentangling the role of the tau gene locus in sporadic tauopathies.
    Vandrovcova J; Anaya F; Kay V; Lees A; Hardy J; de Silva R
    Curr Alzheimer Res; 2010 Dec; 7(8):726-34. PubMed ID: 20704554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untangling the tau gene association with neurodegenerative disorders.
    Pittman AM; Fung HC; de Silva R
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R188-95. PubMed ID: 16987883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
    Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
    Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies.
    Zempel H
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):66-70. PubMed ID: 37795931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau alternative splicing in familial and sporadic tauopathies.
    Niblock M; Gallo JM
    Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
    Langerscheidt F; Wied T; Al Kabbani MA; van Eimeren T; Wunderlich G; Zempel H
    J Neurol; 2024 Jun; 271(6):2992-3018. PubMed ID: 38554150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
    Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
    Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau and MAPT genetics in tauopathies and synucleinopathies.
    Leveille E; Ross OA; Gan-Or Z
    Parkinsonism Relat Disord; 2021 Sep; 90():142-154. PubMed ID: 34593302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Architecture of Primary Tauopathies.
    Gallo D; Ruiz A; Sánchez-Juan P
    Neuroscience; 2023 May; 518():27-37. PubMed ID: 35609758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying tauopathies in Drosophila: A fruitful model.
    Sun M; Chen L
    Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegenerative tauopathies.
    Lee VM; Goedert M; Trojanowski JQ
    Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
    Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
    Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
    Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
    J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.